HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCES AND REVIEW THE LITERATURE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

DEHGHANI SEYED MOHSEN; TAGHAVI SEYED ALIREZA; GERAMIZADEH BITA; NIKEGHBALIAN SAMAN; DERAKHSHAN NIMA; MALEKPOUR ABDORRASOUL; MALEKHOSSEINI SEYED ALI

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2013 | Volume:13 | Issue:1 Page(s): 0-0

Download Full-Text

View:

356

Download:

304

Cites:

Information Journal Paper

Title

HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCES AND REVIEW THE LITERATURE

Author(s)

Keywords

HEPATITIS B VIRUS

LIVER TRANSPLANT

IMMUNOSUPPRESSION

RECURRENCE

Abstract

Background: Despite the advances in the treatment of chronic HEPATITIS B VIRUS (HBV) infection, LIVER TRANSPLANTation (LT) remains the only hope for many patients with end-stage liver diseases resulting from HBV.Objectives: The aim of this study was to investigate the rate of HBV RECURRENCE in cases that had undergone LT due to the HBV related liver cirrhosis.Patients and Methods: Forty-nine patients who underwent LT due to HBV related cirrhosis since 2001 to 2009 in Shiraz Organ Transplantation Center were enrolled in the present study. They were asked to complete the planned questionnaire and also to sign the informed consent in order to take part in this study. Post-transplant prophylaxis protocol against HBV RECURRENCE was based on a hundred milligrams of lamivudine daily plus intramuscular injections of hepatitis B immune globulin (HBIG) with appropriate dosage to keep anti-HBs antibody titer above 300 IU/L and 100 IU/L in the first six months and afterwards, respectively. Blood samples were obtained and checked for HBsAg, HBeAg, and the titers of Anti -HBsAb as well as Anti- HBeAb with ELISA. A quantitative HBV DNA assay was also done on all samples (GENE-RAD® Real-time PCR).Results: There were 91.8% males and 8.2% females enrolled in the study. The duration of post-transplant prophylaxis ranged from 3 months to 8 years (mean 18.9±19.3 months). HBsAg and HBeAg were positive in 24.5% and 2% of cases, respectively. Real-time PCR for HBV DNA were zero copies/mL in 91.8% of patients, none of which represented a positive value for HBV RECURRENCE (Positive>10, 000 copies/mL). The mean Anti-HBs Ab titer was 231.7±135.9 IU/L; it was above 100 IU/L in 71.4% of patients. Thirty-seven (75.5%) of the patients were taking tacrolimus plus mycophenolate mofetil, 6 (12.2%) were on cyclosporine plus mycophenolate mofetil, and 6 (12.2%) were taking sirolimus plus mycophenolate mofetil. HBsAg was detectable in seven patients taking tacrolimus plus mycophenolate mofetil (18.9%), in four patients taking cyclosporine plus mycophenolate mofetil (66.7%), and in one patient among the six who were taking sirolimus plus mycophenolate mofetil (16.7%). There was no significant statistical correlation between the presence of a positive value for HBsAg and the IMMUNOSUPPRESSION regimen or Anti HBsAb titer (P>0.05). Presence of a positive value for HBsAg was not predictive of a positive HBV DNA or its level in blood (P>0.05).Conclusions: Post-transplant HBV prophylaxis with lamivudine and intramuscular HBIG with appropriate dosage to keep anti-HBs antibody titer above 300 IU/L in the first six months and above 100 IU/L afterwards is effective for prevention of HBV RECURRENCE after LT.

Cites

No record.

References

No record.

Cite

APA: Copy

DEHGHANI, SEYED MOHSEN, TAGHAVI, SEYED ALIREZA, GERAMIZADEH, BITA, NIKEGHBALIAN, SAMAN, DERAKHSHAN, NIMA, MALEKPOUR, ABDORRASOUL, & MALEKHOSSEINI, SEYED ALI. (2013). HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCES AND REVIEW THE LITERATURE. HEPATITIS MONTHLY, 13(1), 0-0. SID. https://sid.ir/paper/306863/en

Vancouver: Copy

DEHGHANI SEYED MOHSEN, TAGHAVI SEYED ALIREZA, GERAMIZADEH BITA, NIKEGHBALIAN SAMAN, DERAKHSHAN NIMA, MALEKPOUR ABDORRASOUL, MALEKHOSSEINI SEYED ALI. HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCES AND REVIEW THE LITERATURE. HEPATITIS MONTHLY[Internet]. 2013;13(1):0-0. Available from: https://sid.ir/paper/306863/en

IEEE: Copy

SEYED MOHSEN DEHGHANI, SEYED ALIREZA TAGHAVI, BITA GERAMIZADEH, SAMAN NIKEGHBALIAN, NIMA DERAKHSHAN, ABDORRASOUL MALEKPOUR, and SEYED ALI MALEKHOSSEINI, “HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCES AND REVIEW THE LITERATURE,” HEPATITIS MONTHLY, vol. 13, no. 1, pp. 0–0, 2013, [Online]. Available: https://sid.ir/paper/306863/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops